These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 19308074)

  • 1. Vaccines, global health and social equity.
    Levine MM; Robins-Browne R
    Immunol Cell Biol; 2009; 87(4):274-8. PubMed ID: 19308074
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New tendencies and strategies in international immunisation: GAVI and The Vaccine Fund.
    Martin JF; Marshall J
    Vaccine; 2003 Jan; 21(7-8):587-92. PubMed ID: 12531322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of the GAVI Alliance to improving health and reducing poverty.
    Lob-Levyt J
    Philos Trans R Soc Lond B Biol Sci; 2011 Oct; 366(1579):2743-7. PubMed ID: 21893535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine Assistance To Low- And Middle-Income Countries Increased To $3.6 Billion In 2014.
    Haakenstad A; Birger M; Singh L; Liu P; Lim S; Ng M; Dieleman JL
    Health Aff (Millwood); 2016 Feb; 35(2):242-9. PubMed ID: 26858376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Introducing new vaccines into developing countries: obstacles, opportunities and complexities.
    Clemens J; Jodar L
    Nat Med; 2005 Apr; 11(4 Suppl):S12-5. PubMed ID: 15812482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Costs of vaccine programs across 94 low- and middle-income countries.
    Portnoy A; Ozawa S; Grewal S; Norman BA; Rajgopal J; Gorham KM; Haidari LA; Brown ST; Lee BY
    Vaccine; 2015 May; 33 Suppl 1():A99-108. PubMed ID: 25919184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Why The Decade Of Vaccines?
    Health Aff (Millwood); 2016 Feb; 35(2):188-9. PubMed ID: 26858368
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What have we learned on costs and financing of routine immunization from the comprehensive multi-year plans in GAVI eligible countries?
    Brenzel L
    Vaccine; 2015 May; 33 Suppl 1():A93-8. PubMed ID: 25919183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges for nationwide vaccine delivery in African countries.
    Songane M
    Int J Health Econ Manag; 2018 Jun; 18(2):197-219. PubMed ID: 29047019
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Availability of quality vaccines: policies of a non-government organization.
    Poore P
    Vaccine; 1992; 10(13):958-60. PubMed ID: 1471421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Examining the cost of delivering routine immunization in Honduras.
    Janusz CB; Castañeda-Orjuela C; Molina Aguilera IB; Felix Garcia AG; Mendoza L; Díaz IY; Resch SC
    Vaccine; 2015 May; 33 Suppl 1():A53-9. PubMed ID: 25919175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Global Alliance for Vaccines and Immunization: is it a new model for effective public-private cooperation in international public health?
    Muraskin W
    Am J Public Health; 2004 Nov; 94(11):1922-5. PubMed ID: 15514228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postneonatal mortality impacts following grants from the Gavi Vaccine Alliance: an econometric analysis from 2000 to 2014.
    Kolesar RJ; Audibert M
    Public Health; 2017 Dec; 153():163-171. PubMed ID: 29102832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Return On Investment From Childhood Immunization In Low- And Middle-Income Countries, 2011-20.
    Ozawa S; Clark S; Portnoy A; Grewal S; Brenzel L; Walker DG
    Health Aff (Millwood); 2016 Feb; 35(2):199-207. PubMed ID: 26858370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches.
    Watts E; Sim SY; Constenla D; Sriudomporn S; Brenzel L; Patenaude B
    Value Health; 2021 Jan; 24(1):78-85. PubMed ID: 33431157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strategies to maintain health in the Third World.
    Korte R; Rehle T; Merkle A
    Trop Med Parasitol; 1991 Dec; 42(4):428-32. PubMed ID: 1796244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gavi's Transition Policy: Moving From Development Assistance To Domestic Financing Of Immunization Programs.
    Kallenberg J; Mok W; Newman R; Nguyen A; Ryckman T; Saxenian H; Wilson P
    Health Aff (Millwood); 2016 Feb; 35(2):250-8. PubMed ID: 26858377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The costs of scaling up vaccination in the world's poorest countries.
    Bishai D; McQuestion M; Chaudhry R; Wigton A
    Health Aff (Millwood); 2006; 25(2):348-56. PubMed ID: 16522576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GAVI, the Vaccine Alliance.
    Zerhouni E
    Cell; 2019 Sep; 179(1):13-17. PubMed ID: 31519310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Equity Impact Vaccines May Have On Averting Deaths And Medical Impoverishment In Developing Countries.
    Chang AY; Riumallo-Herl C; Perales NA; Clark S; Clark A; Constenla D; Garske T; Jackson ML; Jean K; Jit M; Jones EO; Li X; Suraratdecha C; Bullock O; Johnson H; Brenzel L; Verguet S
    Health Aff (Millwood); 2018 Feb; 37(2):316-324. PubMed ID: 29401021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.